Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Melanie E Ivey"'
Publikováno v:
Vascular Health and Risk Management, Vol Volume 1, Pp 199-208 (2005)
Soniya Survase1,2, Melanie E Ivey1,2, Julie Nigro1,2, Narin Osman1, Peter J Little1,2,31Cell Biology of Diabetes Laboratory, Baker Heart Research Institute, Melbourne, VIC, Australia; 2Monash University, Department of Medicine (Alfred Hospital), Melb
Externí odkaz:
https://doaj.org/article/66973f4856a34be3b783209d91d9440a
Autor:
Melanie E. Ivey, Peter J. Little
Publikováno v:
Thrombosis Research. 123:288-297
Atherosclerosis is the underlying pathological process of most cardiovascular disease. Thrombin is a serine protease which can activate protease activated receptors (PAR) on vascular smooth muscle cells (VSMC) to elicit cellular responses that can co
Publikováno v:
Current Vascular Pharmacology. 6:195-203
The formation and progression of atherosclerotic plaques followed by rupture, thrombus formation and vessel blockage leads to ischemic tissue damage and the clinical condition underlying most cardiovascular disease. Therapeutic agents for the prevent
Autor:
Peter J. Little, Thomas N. Wight, Julie Nigro, Susan Potter-Perigo, Stephen P. Evanko, Stephanie T. de Dios, Melanie E. Ivey
Publikováno v:
Archives of Physiology and Biochemistry. 114:171-177
PPAR ligands are important effectors of energy metabolism and can modify proteoglycan synthesis by vascular smooth muscle cells (VSMCs). Describing the cell biology of these important clinical agents is important for understanding their full clinical
Autor:
Melanie E. Ivey, Karen V Frontanilla, Peter J. Little, Mandy L. Ballinger, Julie Nigro, Elizabeth A Cawson, Stephanie T. de Dios
Publikováno v:
Journal of Diabetes and its Complications. 21:108-117
The present study aimed to investigate the actions of several classes of oral hypoglycemic agents [e.g., sulfonylureas (SUs), biguanides (BGs) and thiazolidinediones (TZDs)] in an in vitro model of lipid binding based on the "response to retention" h
Autor:
Ronald E. Law, Dennis Bruemmer, Melanie E. Ivey, Stephanie T. de Dios, Garry L. Jennings, Rodney J. Dilley, Peter J. Little
Publikováno v:
Circulation. 107:2548-2550
Background— The proliferation of vascular smooth muscle cells (VSMCs) is a known response to arterial injury that is an important part of the process of restenosis and atherosclerosis. People with diabetes have an increased risk of cardiovascular d
Publikováno v:
Atherosclerosis. 205(2)
Objective: Lipid retention in the vessel wall by glycosaminoglycan (GAG) chains on chondroitin/dermatan sulfate proteoglycans synthesized by vascular smooth muscle cells (VSMC) have recently been established as an early event in human coronary artery
Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells
Autor:
Merlin C. Thomas, Rodney J. Dilley, Peter J. Little, Melanie E. Ivey, Julie Nigro, Mandy L. Ballinger
Publikováno v:
Kidney international. 68(6)
Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells.BackgroundAdvanced glycation end products (AGEs) accumulate in patients with diabetes, particularly at sites of vascular damage and within atheroscle
Publikováno v:
Vascular Pharmacology. 45:e9-e10